One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
What is a Microfluidic Chip?September 27, 20221. Basic definition of microfluidic chipMicrofluidic chip, also known as Lab-on-chip, is a science and technology characterized by the manipulation of fluids in the micron-scale space.At present, the ...view
Development Status and Future of In Vitro Diagnostic TechnologyDecember 15, 2022In vitro diagnostic technology refers to products and services that obtain relevant clinical diagnostic information by testing samples of the body including blood, body fluids, and tissues outside the...view
The Beijing Winter Olympics Has Raised The Curtain On Feb 4, 2022May 19, 2022The Beijing Winter Olympics has raised the curtain on Feb 4, 2022, as thousands of athletes from across the globe gather in China for the first international multi-sport event to be held as scheduled ...view
Microarray Platforms with Various Applications in Genetic ResearchJuly 18, 2024In recent years, the advancements in genetic research have revolutionized our understanding of the human genome. At the forefront of these developments is the Microarray Platform, a pivotal technology...view
Working Principle of Deep-Analysis DNA Microarray TechnologyApril 10, 2024As an important tool in modern biotechnology, DNA microarray scanners play a vital role in genomics, disease diagnosis, drug research and development, and other fields. They can achieve rapid and accu...view